Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 19 studies | 44% ± 20% | |
lung | 16 studies | 28% ± 9% | |
peripheral blood | 16 studies | 28% ± 9% | |
eye | 9 studies | 26% ± 10% | |
intestine | 7 studies | 25% ± 10% | |
kidney | 6 studies | 27% ± 5% | |
heart | 5 studies | 32% ± 5% | |
lymph node | 5 studies | 22% ± 3% | |
liver | 5 studies | 37% ± 14% | |
bone marrow | 4 studies | 33% ± 15% | |
uterus | 4 studies | 35% ± 11% | |
breast | 4 studies | 22% ± 6% | |
adipose | 4 studies | 36% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 14322.27 | 1444 / 1445 | 100% | 26.72 | 183 / 183 |
lung | 99% | 6075.37 | 575 / 578 | 100% | 20.51 | 1153 / 1155 |
breast | 100% | 6197.05 | 459 / 459 | 99% | 22.01 | 1109 / 1118 |
prostate | 100% | 7672.26 | 244 / 245 | 100% | 23.30 | 500 / 502 |
bladder | 100% | 13841.86 | 21 / 21 | 99% | 17.19 | 497 / 504 |
thymus | 100% | 5389.43 | 652 / 653 | 99% | 18.91 | 597 / 605 |
ovary | 100% | 5270.71 | 180 / 180 | 98% | 13.38 | 423 / 430 |
uterus | 100% | 11473.84 | 170 / 170 | 98% | 21.50 | 451 / 459 |
intestine | 100% | 11501.45 | 966 / 966 | 98% | 16.49 | 515 / 527 |
adrenal gland | 98% | 2841.89 | 253 / 258 | 93% | 13.18 | 215 / 230 |
skin | 99% | 5159.91 | 1798 / 1809 | 90% | 16.32 | 426 / 472 |
stomach | 91% | 5942.93 | 328 / 359 | 98% | 19.30 | 280 / 286 |
brain | 90% | 2610.20 | 2366 / 2642 | 100% | 22.12 | 702 / 705 |
kidney | 80% | 2153.51 | 71 / 89 | 95% | 15.90 | 855 / 901 |
pancreas | 34% | 642.91 | 111 / 328 | 98% | 16.66 | 175 / 178 |
blood vessel | 100% | 15031.45 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 5081.78 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 18.56 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.09 | 1 / 1 |
adipose | 100% | 6627.53 | 1201 / 1204 | 0% | 0 | 0 / 0 |
muscle | 97% | 2947.54 | 777 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 19.02 | 28 / 29 |
liver | 27% | 490.65 | 61 / 226 | 65% | 5.67 | 262 / 406 |
heart | 87% | 2744.94 | 749 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 77% | 4369.51 | 711 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 49% | 5.09 | 39 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071466 | Biological process | cellular response to xenobiotic stimulus |
GO_0006470 | Biological process | protein dephosphorylation |
GO_0000278 | Biological process | mitotic cell cycle |
GO_0007165 | Biological process | signal transduction |
GO_0035507 | Biological process | regulation of myosin-light-chain-phosphatase activity |
GO_0007098 | Biological process | centrosome cycle |
GO_0043086 | Biological process | negative regulation of catalytic activity |
GO_0046822 | Biological process | regulation of nucleocytoplasmic transport |
GO_0035508 | Biological process | positive regulation of myosin-light-chain-phosphatase activity |
GO_1903140 | Biological process | regulation of establishment of endothelial barrier |
GO_0030155 | Biological process | regulation of cell adhesion |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0005886 | Cellular component | plasma membrane |
GO_0030018 | Cellular component | Z disc |
GO_0005813 | Cellular component | centrosome |
GO_0000776 | Cellular component | kinetochore |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005925 | Cellular component | focal adhesion |
GO_0043292 | Cellular component | contractile muscle fiber |
GO_0001725 | Cellular component | stress fiber |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0031672 | Cellular component | A band |
GO_0005737 | Cellular component | cytoplasm |
GO_0072357 | Cellular component | PTW/PP1 phosphatase complex |
GO_0004857 | Molecular function | enzyme inhibitor activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0071889 | Molecular function | 14-3-3 protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0019208 | Molecular function | phosphatase regulator activity |
Gene name | PPP1R12A |
Protein name | Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit) Protein phosphatase 1 regulatory subunit 12A |
Synonyms | MBS MYPT1 |
Description | FUNCTION: Key regulator of protein phosphatase 1C (PPP1C). Mediates binding to myosin. As part of the PPP1C complex, involved in dephosphorylation of PLK1. Capable of inhibiting HIF1AN-dependent suppression of HIF1A activity. . |
Accessions | O14974 ENST00000261207.9 [O14974-1] ENST00000550107.5 [O14974-3] H0YHL8 H0YIS3 ENST00000548318.1 ENST00000650220.1 ENST00000634739.1 ENST00000550903.5 A0A0U1RQZ1 ENST00000546369.5 [O14974-5] ENST00000437004.6 [O14974-2] F8VZN8 ENST00000550510.5 H0YIL7 H0YHI8 H0YIS4 ENST00000553081.5 ENST00000547131.1 ENST00000550299.5 ENST00000450142.7 [O14974-1] A0A3B3ISH4 F8VW28 ENST00000546762.5 H0YIM2 ENST00000547330.5 |